相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
Karen Bush
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Determining a clinical framework for use of cefepime and -lactam/-lactamase inhibitors in the treatment of infections caused by extended-spectrum--lactamase-producing Enterobacteriaceae
Hien M. Nguyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 US Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam
Michael N. Dudley et al.
CLINICAL INFECTIOUS DISEASES (2013)
10 x '20 Progress-Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2013)
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Andrea Endimiani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Potency and spectrum trends for cefepime tested against 65,746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998-2003)
HS Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)